166 followers
PubMed_ Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report https://t.co/03Htup4RXS
PubMed_ Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report https://t.co/03Htup4RXS
New research: Acquired ALK G1202R-, ALK I1171N-, or EML4-ALK-mediated resistance to ensartinib in lung adenocarcinoma but responded to lorlatinib: A case report: ALK rearrangements are identified as driver mutations in non-small-cell lung… https://t.co/r7k